PTUPB ameliorates high-fat diet-induced non-alcoholic fatty liver disease via inhibiting NLRP3 inflammasome activation in mice

Non-alcoholic fatty liver disease (NAFLD) affects 25% of the global adult population, and no effective pharmacological treatment has been found. Products of arachidonic acid metabolism have been developed into a novel therapy for metabolic syndrome and diabetes. It has been demonstrated that protect...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Biochem Biophys Res Commun
Main Authors: Sun, Chen-Chen, Zhang, Chen-Yu, Duan, Jia-Xi, Guan, Xin-Xin, Yang, Hui-Hui, Jiang, Hui-Ling, Hammock, Bruce D., Hwang, Sung Hee, Zhou, Yong, Guan, Cha-Xiang, Liu, Shao-Kun, Zhang, Jun
Formato: Artigo
Idioma:Inglês
Publicado: 2020
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7990110/
https://ncbi.nlm.nih.gov/pubmed/31973813
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbrc.2019.12.131
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares